Change Requests

What is an ICR?

An Information Collection Request (ICR) is a federal agency's request for approval from the Office of Management and Budget (OMB) to collect information from the public. Under the Paperwork Reduction Act (PRA), agencies must justify why the information is needed and how it will be used.

When are they submitted?

Federal agencies are required to submit an ICR whenever they create, renew, modify an information collection. Each ICR includes a description of the collection, supporting materials and documentation (such as forms, surveys, or scripts), and proof that the agency has met the requirements of the PRA.

The ICR is submitted to the The Office of Information and Regulatory Affairs (OIRA) within OMB for review and approval. OIRA grants approval for a maximum of three years, after which the collection must be renewed through a new ICR submission.

Where to find an ICR?

ICRs are publicly available on RegInfo.gov, and additional guidance can be found in the FAQs.

Note: Presidential Action influences are notated for ICRs received between January 20, 2025 and July 19, 2025.

Full Inventory
Under Review
Presidential Action Driven

Showing 25 of 15036 results

CSV Download

Title
Reference Number
OMB Control Number
Agency
Received
Concluded
Action
Status
Request Type
Presidential Action

Title:

Third Party Testing of Children's Products

Reference Number:

202506-3041-004

Omb Control Number:

3041-0159

Agency:

CPSC

Received:

2025-09-30

Concluded:

2025-12-08

Action:

Approved with change

Status:

Active

Request Type:

Revision of a currently approved collection
Third Party Testing of Children's Products

Key Information

Abstract

This information collection request covers the record keeping requirements set forth in a final rule on Testing and Labeling Pertaining to Product Certification (16 CFR part 1107; the testing rule), as well as the record keeping and third party disclosure requirements set forth in a final rule on Conditions and Requirements for Relying on Component Part Testing or Certification, or Another Party's Finished Product Testing or Certification to Meet Testing and Certification Requirements (16 CFR part 1109; the component part rule). It also covers the burden of labeling and marking children's products associated with rules passed under section 104 of the CPSIA. Lastly, it covers manufacturers and importers of Electrically Operated Toys and Baby-Bouncer/Walker-Jumpers requirements on labeling and keeping records of the sale and distribution of the products.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

15 USC 2063(a)(2)
View Law
15 USC 2063(i)(2)(B)
View Law
Pub.L. 110 - 314 104(b)
View Law

Presidential Action:

-

Title:

National Prisoner Statistics-Prison Population Reports: NPS-1B, Summary of Sentenced Population Movement

Reference Number:

202507-1121-002

Omb Control Number:

1121-0102

Agency:

DOJ/OJP

Received:

2025-09-30

Concluded:

2025-12-11

Action:

Approved without change

Status:

Active

Request Type:

Revision of a currently approved collection
National Prisoner Statistics-Prison Population Reports: NPS-1B, Summary of Sentenced Population Movement

Key Information

Abstract

Through the National Prisoner Statistics program (NPS), the Bureau of Justice Statistics (BJS) collects annual aggregate counts of prisoners in the custody and under the jurisdiction of state and federal correctional authorities, as well as the number of persons admitted or released. BJS uses the NPS to report each year on the changes to and movement through state and federal prison systems by sentenced individuals. These statistics are part of BJS’s core corrections statistics, as they contribute fundamentally to BJS’s mission of describing the movements of persons through the criminal justice system. The current NPS collection approved by the Office of Management and Budget (OMB # 1121-0102), due to expire January 31, 2026 (National Prisoner Statistics-Prison Population Reports: NPS-1B, Summary of Sentenced Population Movement), collects information on the prison population on December 31st of each year. The NPS-1B collects prisoner counts by race/ethnicity, the number of admissions and releases in the calendar year (by type), and capacity figures. BJS is requesting a 3-year clearance. This clearance request will cover BJS collection of prison data from 2025-2027, collected in calendar years 2026-2028.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

34 USC 10132
View Law

Presidential Action:

-

Title:

Energy Efficiency and Conservation Block Grant

Reference Number:

202509-1910-001

Omb Control Number:

1910-5150

Agency:

DOE/DOEOA

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Extension without change of a currently approved collection
Energy Efficiency and Conservation Block Grant

Key Information

Abstract

EECBG is a program, authorized by the Energy Independence and Security Act which provides Federal financial assistance and technical support to state and local governments and tribal nations to carry out activities designed to save energy, create and retain jobs, increase energy efficiency, and decrease harmful emissions. Many of the grant recipients are unfamiliar with the provisions surrounding the expenditure of Federal funds and the vast majority has not had a pre-existing professional relationship with DOE. The size and pace of EECBG Program execution create an urgent need for DOE to collect certain information on a quarterly basis in order to adequately monitor, report, and ensure transparency and accountability.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

Pub.L. 110 - 140 all
View Law

Presidential Action:

-

Title:

Registration of Food Facilities

Reference Number:

202509-0910-007

Omb Control Number:

0910-0502

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

2025-11-14

Action:

Approved without change

Status:

Active

Request Type:

Extension without change of a currently approved collection
Registration of Food Facilities

Key Information

Abstract

Respondents to the information collection are manufacturers, processors, holders, and distributors of foods who must register with the agency. Through this registration program and the information provided under the regulations, the agency is able to identify firms in the event of food-related emergencies as well as ensure that contaminated food products are quickly and efficiently removed from the marketplace.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 301 et seq.
View Law

Presidential Action:

-

Title:

Production, Storage, and Transportation of Shell Eggs (preventing Salmonella Enteritidis (SE))

Reference Number:

202501-0910-005

Omb Control Number:

0910-0660

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

2025-11-14

Action:

Approved without change

Status:

Active

Request Type:

Extension without change of a currently approved collection
Production, Storage, and Transportation of Shell Eggs (preventing Salmonella Enteritidis (SE))

Key Information

Abstract

This collection requires producers of shell eggs to maintain records and provide reports regarding the implementation of preventative measures to ensure that eggs contaminated with salmonella enteritidis do not reach the public marketplace.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 342
View Law
21 USC 371
View Law

Presidential Action:

-

Title:

Protection and Advocacy of Individuals With Mental Illness (PAIMI) Annual Program Performance Report

Reference Number:

202509-0930-006

Omb Control Number:

0930-0169

Agency:

HHS/SAMHSA

Received:

2025-09-30

Concluded:

2025-11-17

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Protection and Advocacy of Individuals With Mental Illness (PAIMI) Annual Program Performance Report

Key Information

Abstract

The PAIMI formula grant program provides funds to support activities on behalf of individuals with mental illness. Recipients of program funding are required by law to report annually such information as the number of individuals served, types of facilities involved, and their priorities, activities and accomplishments. The PAIMI Annual Program Performance Report must also include a separate report prepared by the PAIMI Advisory Council describing its activities and assessing the operation of the protection and advocacy system.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 520
View Law

Presidential Action:

-

Title:

Negotiation Program Drug Selection for Initial Price Applicability Year 2028 (CMS-10844) - IRA

Reference Number:

202509-0938-014

Omb Control Number:

0938-1443

Agency:

HHS/CMS

Received:

2025-09-30

Concluded:

2025-11-10

Action:

Approved without change

Status:

Active

Request Type:

Revision of a currently approved collection
Negotiation Program Drug Selection for Initial Price Applicability Year 2028 (CMS-10844) - IRA

Key Information

Abstract

In accordance with section 1192(d)(2) of the Act, the term “negotiation-eligible drug” excludes, with respect to the initial price applicability years 2026, 2027, and 2028, a qualifying single source drug that meets the requirements for the exception for small biotech drugs (the “Small Biotech Exception,” or “SBE”). This information is required in order for CMS to accurately identify whether a given drug meets the criteria for the Small Biotech Exception in accordance with section 1192(d)(2) of the Act. To ensure that drugs covered under Part B and/or Part D that meet the requirements for the SBE are excluded from the term “negotiation-eligible drug,” a manufacturer that seeks the SBE for its drug covered under Part B and/or Part D (“Submitting Manufacturer”) must submit information to CMS about the company and its products in order for the drug to be considered for the exception. If the Submitting Manufacturer seeks the SBE for a drug covered under Part B and/or Part D it acquired after December 31, 2021, the Submitting Manufacturer must also submit information related to the separate entity that had the Medicare Coverage Gap Discount Program agreement for the drug on December 31, 2021 for drugs covered under Part D and information related to the holder of the New Drug Application(s) (NDA)(s) or Biologics License Applications(s) (BLA)(s) as of December 31, 2021 for drugs covered under Part B. If the Submitting Manufacturer was acquired by another entity after December 31, 2021, the Submitting Manufacturer must provide information regarding that acquiring entity for CMS to assess whether the acquisition triggers the limitation at section 1192(d)(2)(B)(ii) of the Act. Under section 1192(f)(1)(B) of the Act, the manufacturer of a biosimilar biological product (“Biosimilar Manufacturer” of a “Biosimilar”) may submit a request, prior to the selected drug publication date, for CMS’ consideration to delay the inclusion of a negotiation-eligible drug that includes the reference product for the Biosimilar (such a negotiation-eligible drug is herein referred to as a “Reference Drug”) on the selected drug list for a given initial price applicability year. CMS needs to collect information to identify the Biosimilar Drug, the Reference Drug, the Biosimilar Manufacturer and the Section 1194(f) of the Act establishes the requirements governing the identification of renegotiation-eligible drugs and selection of drugs for renegotiation. CMS must collect information from Primary Manufacturers to determine which selected drugs qualify as a renegotiation-eligible drug and may be selected for renegotiation in accordance with section 1194(f)(3) of the Act. Specifically, section 1194(f)(2)(D) of the Act instructs CMS to identify whether a selected drug is eligible for renegotiation based on a material change to any of the factors listed in section 1194(e) of the Act, which include the data in section 1194(e)(1) that must be submitted by the Primary Manufacturer of a selected drug. Additionally, once a drug has been selected for renegotiation, CMS must also consider section 1194(e)(1) data during the renegotiation period in the development of offers and consideration of counteroffers.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

Pub.L. 117 - 169 11001 and 11002
View Law

Presidential Action:

-

Title:

Mitigation Strategies to Protect Food Against Intentional Adulteration

Reference Number:

202509-0910-006

Omb Control Number:

0910-0812

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

2025-11-14

Action:

Approved without change

Status:

Active

Request Type:

Reinstatement without change of a previously approved collection
Mitigation Strategies to Protect Food Against Intentional Adulteration

Key Information

Abstract

This information collection supports agency regulations that relate to the development of mitigation strategies to protect against the intentional adulteration of food. Respondents to the collection are food production facilities subject to agency regulations.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 350g
View Law
21 USC 350i
View Law

Presidential Action:

-

Title:

Fast Track Generic Clearance for Collection of Qualitative Feedback on Agency Service Delivery

Reference Number:

202509-0970-013

Omb Control Number:

0970-0401

Agency:

HHS/ACF

Received:

2025-09-30

Concluded:

2025-09-30

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Fast Track Generic Clearance for Collection of Qualitative Feedback on Agency Service Delivery

Key Information

Abstract

This request is for a revision. There are no changes to the proposed types or the uses of the information collected through Generic Information Collections (GenICs) submitted under the Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (0970-0401). Burden estimates have been updated to reflect the Administration for Children and Families’ (ACF’s) use of this generic mechanism since the most recent approval in 2021 and anticipated use over the next three years. ACF is in the process of making updates to GenICs through nonsubstantive change requests to ensure compliance with executive orders Ending Radical and Wasteful Government DEI Programs and Preferencing and Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 1310
View Law

Presidential Action:

-

Title:

Medicare Part D Manufacturer Discount Program Agreement - IRA (CMS-10846)

Reference Number:

202509-0938-022

Omb Control Number:

0938-1451

Agency:

HHS/CMS

Received:

2025-09-30

Concluded:

2025-12-30

Action:

Approved without change

Status:

Active

Request Type:

Revision of a currently approved collection
Medicare Part D Manufacturer Discount Program Agreement - IRA (CMS-10846)

Key Information

Abstract

Section 11201 of the Inflation Reduction Act of 2022 (IRA), eliminates the coverage gap phase of the Part D benefit and sunsets the coverage gap discount program after December 31, 2024, and amends the Social Security Act (the Act) to add §1860D-14C, requiring the Secretary to establish a new Medicare Part D manufacturer discount program (Discount Program) beginning January 1, 2025. Under the Discount Program, participating manufacturers are required to provide discounts on their “applicable drugs” (brand drugs, biologics, and biosimilars) both in the initial coverage phase and in the catastrophic coverage phase of the Part D benefit. Section 1860D-14C(d)(1) of the Act requires CMS to implement and administer the Discount Program, including determining discounted amounts, and ensuring that discounts are applied appropriately and payments/reimbursements are timely made. As with the existing coverage gap discount program, a CMS contractor will serve as the third party administrator (TPA) and facilitate payment processing. Information in this collection is needed to set up agreements between manufacturers and CMS, as required under §1860D-14C(a) of the Act. Such agreements are required in order for manufacturers to participate in the Discount Program and, under §1860D43(a), for their applicable drugs to be covered under Part D beginning in 2025. Information that will be collected from manufacturers in the Health Plan Management System (HPMS) (Appendix A) is needed to create and execute Discount Program agreements and to determine which manufacturers qualify as a specified manufacturer or specified small manufacturer for phased-in discounts, as described at §1860D-14C(g)(4). Banking information collected by the TPA from manufacturers and plan sponsors (Appendix B) is needed to prepare invoices and process financial transactions (deposits and payments) through the automated clearing house (ACH).

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 1395w-114c
View Law
Pub.L. 117 - 117 11201
View Law

Presidential Action:

-

Title:

Collection of grant and contract data that may be of interest to Historically Black Colleges and Universities (HBCUs) and small businesses (OD/OALM)

Reference Number:

202509-0925-002

Omb Control Number:

0925-0767

Agency:

HHS/NIH

Received:

2025-09-30

Concluded:

2025-11-19

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Collection of grant and contract data that may be of interest to Historically Black Colleges and Universities (HBCUs) and small businesses (OD/OALM)

Key Information

Abstract

This is an extension request to continue to collect data past the current expiration date. This effort supports the NIH Path to Excellence and Innovation (PEI) Program formed in accordance with Presidential Executive Order 13779, The White House Initiative to Promote Excellence and Innovation at Historically Black Colleges and Universities (HBCUs). The HBCU pre-solicitation portal is a tool to collect NIH contracts and grants data that HBCUs and their business teaming partners may be interested in pursuing. The portal provides a streamlined platform for NIH funding opportunities that consolidate information from four different Federal websites. Additionally, this tool has a social networking component that creates a space for HBCUs and businesses to collaborate as they pursue of NIH funding opportunities. Through the collection and analysis of this information, the National Institutes of Health (NIH) Small Business Program Office (SBPO) assists in strengthening HBCUs’ ability to equitably participate in Federal funding programs.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Presidential Action:

-

Title:

Risk Management Program Requirements and Petitions to Modify the List of Regulated Substances under Section 112(r) of the Clean Air Act (Renewal)

Reference Number:

202509-2050-001

Omb Control Number:

2050-0144

Agency:

EPA/OLEM

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Extension without change of a currently approved collection
Risk Management Program Requirements and Petitions to Modify the List of Regulated Substances under Section 112(r) of the Clean Air Act (Renewal)

Key Information

Abstract

This information collection is authorized by the following Clean Air Act (CAA) sections: for on-site documentation of Risk Management Plans (RMPs), section 112(r)(7)(B)(i) and (ii); for submitting an RMP, section 112(r)(7)(B)(iii); and, for on-site documentation and submittal of RMPs, section 114(a)(1). State and local authorities use the information in RMPs to modify and enhance their community response plans. The agencies implementing the Risk Management Program use RMPs to evaluate compliance with the Chemical Accident Prevention Provisions in 40 CFR part 68 and to identify sources for inspection that may pose significant risks to the community. Citizens may use the information to assess and address chemical hazards in their communities and to respond appropriately in the event of a release of a regulated substance.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

Pub.L. 91 - 604 112(r)
View Law

Presidential Action:

-

Title:

Application and Reports for Paleontological Permits, 43 CFR 49

Reference Number:

202509-1093-001

Omb Control Number:

1093-0008

Agency:

DOI/OS

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Revision of a currently approved collection
Application and Reports for Paleontological Permits, 43 CFR 49

Key Information

Abstract

The Paleontological Resources Preservation Act (PRPA) was enacted to preserve paleontological resources for current and future generations because these resources are nonrenewable and are an irreplaceable part of America’s heritage. PRPA requires that implementation be coordinated between the Secretaries of the Interior and Agriculture and that DOI and USDA issue regulations as appropriate to carry out the law. We (DOI) are proposing regulations to implement the PRPA. The proposed rule would preserve, manage, and protect paleontological resources on BLM, NPS, Reclamation, and FWS lands and ensure that these resources are available for current and future generations to enjoy as part of America’s national heritage. The rule would address the management, collection, and curation of paleontological resources from Federal lands using scientific principles and expertise, including collection in accordance with permits, curation in an approved repository, maintenance of confidentiality of specific locality data, and authorization of penalties for illegal collecting, damaging, otherwise altering or defacing, or sale of paleontological resources. Information collected will allow the DOI bureaus to inventory paleontological resources, implement the permitted collection of fossils from the ground, preserve collected fossils in repositories, track and report the location and condition of paleontological resources, implement the civil penalties provisions with due process considerations, and monitor the results of scientific investigations that involve the use of paleontological resources in both the field and in museum collections.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

16 USC 470aaa – aaa-11
View Law

Presidential Action:

-

Title:

Citizenship and Immigration Services Ombudsman Request for Case Assistance Form (DHS Form 7001)

Reference Number:

202508-1601-001

Omb Control Number:

1601-0004

Agency:

DHS/OS

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Revision of a currently approved collection
Citizenship and Immigration Services Ombudsman Request for Case Assistance Form (DHS Form 7001)

Key Information

Abstract

This information collection will be used by the Citizenship and Immigration (CIS) Ombudsman to identify problem areas, propose changes, and assist individuals experiencing problems during the processing of an immigration benefit with U.S. Citizenship and Immigration Services (USCIS)

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

Pub.L. 107 - 296 452
View Law

Presidential Action:

-

Title:

Monitoring Data Collection Tools for the Minority AIDS Initiative (MAI)

Reference Number:

202509-0930-004

Omb Control Number:

0930-0357

Agency:

HHS/SAMHSA

Received:

2025-09-30

Concluded:

2025-11-17

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Monitoring Data Collection Tools for the Minority AIDS Initiative (MAI)

Key Information

Abstract

The Minority AIDS Initiative (MAI) monitoring tools includes both youth and adult questionnaires as well as the quarterly progress report. The target population for the MAI grantees will be at-risk minority adolescents and young adults. All MAI grantees are expected to report their monitoring data using SAMHSA’s Strategic Prevention Framework (SPF) to target minority populations, as well as other high risk groups residing in communities of color with high prevalence of Substance Abuse and HIV/AIDS.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

5 USC 516
View Law

Presidential Action:

-

Title:

NSPS for Stationary Gas Turbines (40 CFR Part 60, Subpart GG) (Renewal)

Reference Number:

202508-2060-002

Omb Control Number:

2060-0028

Agency:

EPA/OAR

Received:

2025-09-30

Concluded:

2025-12-15

Action:

Approved without change

Status:

Active

Request Type:

Extension without change of a currently approved collection
NSPS for Stationary Gas Turbines (40 CFR Part 60, Subpart GG) (Renewal)

Key Information

Abstract

The New Source Performance Standards (NSPS) for Stationary Gas Turbines (40 CFR Part 60, Subpart GG) were promulgated on September 10, 1979; and last-amended on February 27, 2014. These regulations apply to both existing facilities and new facilities that have stationary gas turbines with a heat input at peak load equal or greater than 10.7 gigajoules per hour (based on the lower heating value of the fuel fired). There are no new facilities under this subpart, as any facility which commenced either construction, or modification, or reconstruction after February 18, 2005 is subject to the NSPS for Stationary Combustion Turbines (40 CFR Part 60, Subpart KKKK). This information is being collected to assure compliance with 40 CFR Part 60, Subpart GG. In general, all NSPS standards require initial notifications, performance tests, and periodic reports by the owners/operators of the affected facilities. They are also required to maintain records of the occurrence and duration of any startup, shutdown, or malfunction in the operation of an affected facility, or any period during which the monitoring system is inoperative. These notifications, reports, and records are essential in determining compliance, and are required of all affected facilities subject to NSPS.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 7401 et seq
View Law

Presidential Action:

-

Title:

Children's Hospital Graduate Medical Education Program

Reference Number:

202509-0915-004

Omb Control Number:

0915-0247

Agency:

HHS/HSA

Received:

2025-09-30

Concluded:

2025-12-22

Action:

Approved without change

Status:

Active

Request Type:

Revision of a currently approved collection
Children's Hospital Graduate Medical Education Program

Key Information

Abstract

The Children’s Hospitals Graduate Medical Education (CHGME) Payment Program provides Federal support for graduate medical education to freestanding children’s hospitals. Eligible children’s hospitals receive payments for both direct and indirect medical education. Data based on the number of FTE residents trained in applicant children’s hospital and teaching health center training programs is needed to determine the amount of graduate medical education payments to be distributed to participating children’s hospitals and teaching health centers. Children’s hospitals and teaching health centers applying for and receiving CHGME Payment Program and THCGME Program funds and fiscal intermediaries auditing data submitted by the participating children’s hospitals and teaching health centers are the anticipated respondents. If this data is not collected, HRSA will have no means to monitor grantees, verify grantee reporting, or determine grantee eligibility for CHGME funding.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

Pub.L. 115 - 241 340E
View Law

Presidential Action:

-

Title:

Assessment of the Underage Drinking Prevention Initiative

Reference Number:

202509-0930-008

Omb Control Number:

0930-0288

Agency:

HHS/SAMHSA

Received:

2025-09-30

Concluded:

2025-11-17

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Assessment of the Underage Drinking Prevention Initiative

Key Information

Abstract

To help address the problem of underage drinking (UAD) and its consequences, SAMHSA sponsors nationwide Communities Talk activities approximately every 2 years. These activities are intended to work at the grassroots level to raise awareness of the public health dangers of UAD and to engage communities in evidence-based prevention. Notably, Communities Talk activities provide a forum for communities to discuss ways they can best prevent UAD by reducing the availability of alcohol and by creating community norms that discourage demand. The information is collected to document the implementation efforts of this nationwide initiative, determine if the federally sponsored activities lead to additional activities within the community that are aimed at preventing and reducing UAD, identify what these activities may possibly include, and help plan for future rounds of Communities Talk.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 505
View Law

Presidential Action:

-

Title:

Conditions of Participation for Community Mental Health Centers and Supporting Regulations (CMS-10506)

Reference Number:

202509-0938-025

Omb Control Number:

0938-1245

Agency:

HHS/CMS

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Reinstatement without change of a previously approved collection
Conditions of Participation for Community Mental Health Centers and Supporting Regulations (CMS-10506)

Key Information

Abstract

The information collection requirements contained in this information collection request are among other requirements classified as (or known as) the CoPs which are based on criteria prescribed in law and are standards designed to ensure that each facility has properly trained staff to provide the appropriate safe physical environment for patients. These particular standards reflect comparable standards developed by industry organizations such as the Joint Commission. The primary users of this information will be State agency surveyors, CMS and community mental health centers (CMHCs )for the purpose of ensuring compliance with Medicare CoPs as well as ensuring the quality of care provided by CMHCs to patients.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 1395k
View Law
42 USC 1395x(ff)(3)
View Law
Pub.L. 101 - 508 4162
View Law

Presidential Action:

-

Title:

Annual Reports for Projects for Assistance in Transition from Homelessness (PATH)

Reference Number:

202509-0930-010

Omb Control Number:

0930-0205

Agency:

HHS/SAMHSA

Received:

2025-09-30

Concluded:

2025-11-17

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Annual Reports for Projects for Assistance in Transition from Homelessness (PATH)

Key Information

Abstract

The PATH program provides funding to help States and territories provide flexible, community-based services for individuals with serious mental illnesses who are homeless or at imminent risk of becoming homeless. There is a statutory requirement that States and territories receiving funding under this formula grant program provide a report not later than January 31 a description of the purposes for which funds were expended during the preceding fiscal year and of the recipients of the monies, and determining whether such amounts were expended in accordance with the provisions of the legislation.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

42 USC 522
View Law

Presidential Action:

-

Title:

Establishing That a Tobacco Product Was Commercially Marketed in the United States As of February 15, 2007

Reference Number:

202509-0910-002

Omb Control Number:

0910-0775

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Extension without change of a currently approved collection
Establishing That a Tobacco Product Was Commercially Marketed in the United States As of February 15, 2007

Key Information

Abstract

The guidance document provides information on how a manufacturer may establish that a tobacco product was commercially marketed in the United States as of February 15, 2007. A "Pre-Existing" tobacco product is not considered a new tobacco product and thus is not subject to the premarket requirements of the FD&C Act. A Pre-Existing tobacco product may also serve as the predicate tobacco product in a section 905(j) report (intended to be used toward demonstrating substantial equivalence) for a new tobacco product (section 905(j)(1)A)(i) of the FD&C Act( 21 U.S.C. 387e(j)(1)(A)(i))). FDA interprets the phrase "as of February 15, 2007," as meaning that the tobacco product was commercially marketed in the United States on February 15, 2007. The guidance associated with this collection of information recommends that the manufacturer submit information adequate to demonstrate that the tobacco product was commercially marketed in the United States as of February 15, 2007. Examples of such information may include, but are not limited to, the following: dated copies of advertisements, dated catalog pages, dated promotional material, and dated bills of lading.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 387
View Law
Pub.L. 111 - 111 31
View Law

Presidential Action:

-

Title:

Crash Avoidance Warning System Human-Machine Interface Research

Reference Number:

202509-2127-005

Omb Control Number:

-

Agency:

DOT/NHTSA

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

New collection (Request for a new OMB Control Number)
Crash Avoidance Warning System Human-Machine Interface Research

Key Information

Abstract

The National Highway Traffic Safety Administration (NHTSA) is seeking approval for this new information collection request (ICR) to conduct 6 new voluntary information collections as part of a one-time research program examining drivers’ interactions with crash avoidance technology with different human-machine interface (HMI) characteristics. Crash avoidance warning systems aid vehicle drivers in avoiding crashes by presenting alerts and warnings to inform drivers of situations in which the system has determined, via sensor information, that a crash is possible. These systems communicate the occurrence of such conditions to drivers via different sensory modalities, such as visual or auditory signals or vibration of the seat or steering wheel. The research will examine how the characteristics of the visual, auditory, and/or haptic (i.e., touch) signals presented by the system may affect the driver’s response to a crash-imminent situation. This research will help inform NHTSA’s rulemaking activities relating to crash avoidance technologies. The research will involve driver behavior observation while driving on a test track, public road, or in a simulated environment (i.e., driving simulator) as means of collecting needed data. Data collection may also involve stationary laboratory measurements relating to crash avoidance warning signal characteristics, such as stationary laboratory measurements of individuals’ visual angles when gazing at in-vehicle visual signals (e.g., instrument panel symbols) and displays. Experimental data collection will include measurements such as those relating to driving performance, vehicle control metrics, and eye glance behavior. Study participants are members of the general public and include licensed car and/or commercial truck drivers aged 25 to 65 who are healthy and able to drive without assistive devices. The full information collection request includes six information collections: Interest Response Form, Candidate Screening Questions, Appointment Scheduling, Informed Consent, Experimental Data Collection, and Post-Drive Questionnaire. Data collection will begin upon receipt of PRA clearance. Response to this information collection is voluntary and will be conducted in phases corresponding to the different crash avoidance warning system types to be examined (i.e., forward, lateral, and rear crash avoidance). This is a new information collection that is estimated at 239 annual burden hours and $7,200 annual opportunity costs.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Presidential Action:

-

Title:

Mental Health Client/Consumer Outcome Measures and Infrastructure, Prevention and Promotion Indicators

Reference Number:

202509-0930-011

Omb Control Number:

0930-0285

Agency:

HHS/SAMHSA

Received:

2025-09-30

Concluded:

2025-11-17

Action:

Approved without change

Status:

Active

Request Type:

No material or nonsubstantive change to a currently approved collection
Mental Health Client/Consumer Outcome Measures and Infrastructure, Prevention and Promotion Indicators

Key Information

Abstract

SAMHSA and its Centers will use the data collected for annual reporting required by GPRMA, to describe and understand changes in outcomes from baseline to follow-up to discharge. SAMHSA’s report for each fiscal year will include actual results of performance monitoring for the three preceding fiscal years. Information collected through this request will allow SAMHSA to report on the results of these performance outcomes as well as be consistent with SAMHSA-specific performance domains, and to assess the accountability and performance of its discretionary grant programs. The additional information collected through this request will allow SAMHSA to improve its ability to assess the impact of its programs on key outcomes of interest and to gather vital diagnostic information about clients served by CMHS discretionary grant programs. SAMHSA is in the process of establishing a new data collection tool for client services which will be used by discretionary grants from both CMHS and the Center for Substance Abuse Treatment (CSAT). While working towards this new combined data collection, SAMHSA is requesting to extend the time period for data collection using the currently approved tools without change to the tools.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

5 USC 1105
View Law

Presidential Action:

-

Title:

Food Safety, Health, and Diet Survey

Reference Number:

202407-0910-012

Omb Control Number:

0910-0345

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

None

Action:

None

Status:

Received in OIRA

Request Type:

Reinstatement with change of a previously approved collection
Food Safety, Health, and Diet Survey

Key Information

Abstract

The goal of this voluntary survey is to measure consumers' knowledge, attitudes, beliefs, and reported behavior about food safety and various topics related to health, nutrition, and physical activity. Data will be used to evaluate four proposed Healthy People 2030 objectives related to consumer food safety and help to evaluate and develop strategies and programs to encourage consumers to adopt healthy lifestyles through making better informed nutrition choices by using Nutrition Facts and menu labeling information.

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 393
View Law

Presidential Action:

-

Title:

Sanitary Transportation of Human and Animal Food

Reference Number:

202412-0910-005

Omb Control Number:

0910-0773

Agency:

HHS/FDA

Received:

2025-09-30

Concluded:

2025-11-14

Action:

Approved without change

Status:

Active

Request Type:

Extension without change of a currently approved collection
Sanitary Transportation of Human and Animal Food

Key Information

Abstract

The Food and Drug Administration is establishing requirements for shippers, carriers by motor vehicle and rail vehicle, and receivers engaged in the transportation of food, including food for animals, to use sanitary transportation practices to ensure the safety of the food they transport. This action is part of our larger effort to focus on prevention of food safety problems throughout the food chain and is part of our implementation of the Sanitary Food Transportation Act of 2005 (2005 SFTA) and the FDA Food Safety Modernization Act of 2011 (FSMA).

Federal Register Notices

60-Day FRN
View Notice
30-Day FRN
View Notice

Authorizing Statutes

21 USC 371(a) et al.
View Law

Presidential Action:

-
Subscribe